Leo Twiggs | Academic Influence

Q: What Schools Are Affiliated With Leo Twiggs

Leo Twiggs is affiliated with the following schools: University of Georgia, South Carolina State University, New York University, University of Minnesota, Claflin University

Why Is Leo Twiggs Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Leo Franklin Twiggs is an American painter. He developed the Fine Art Department at South Carolina State University, where he taught from 1973 until 1998. Twiggs received his Bachelor of Arts degree from Claflin University in 1956 and his Master of Arts degree from New York University in 1964. In 1970, Twiggs became the first African American student to receive a Doctorate of Arts from the University of Georgia. He has presented over fifty one-man shows during his career.

(See a Problem?)

Leo Twiggs's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Papers

2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities. (2002) (995)
2001 Consensus Guidelines for the management of women with cervical cytological abnormalities (2002) (727)
Interim Guidelines for Management of Abnormal Cervical Cytology (1994) (556)
Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. (1992) (383)
Vascular endothelial growth factor expression in early stage ovarian carcinoma (1997) (369)
Case-control study of endogenous steroid hormones and endometrial cancer. (1996) (284)
2001 Consensus guidelines for the management of women with cervical intraepithelial neoplasia. (2003) (228)
Relation of endometrial cancer risk to past and contemporary body size and body fat distribution. (1993) (151)
Pretreatment surgical staging of patients with cervical carcinoma (1998) (150)
Serum and ascitic fluid levels of interleukin‐1, interleukin‐6, and tumor necrosis factor‐alpha in patients with ovarian epithelial cancer (1993) (144)
Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas. (1997) (141)
Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas. (1997) (138)
Human papillomavirus types and localization in adenocarcinoma and adenosquamous carcinoma of the uterine cervix: a study by in situ DNA hybridization. (1988) (135)
Erythropoietin increases hemoglobin during radiation therapy for cervical cancer. (1994) (129)
Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors. (1998) (129)
Malignant Rhabdoid Tumor of the Vulva: Is Distinction from Epithelioid Sarcoma Possible? A Pathologic and Immunohistochemical Study (1989) (104)
Lymph node yield from laparoscopic lymphadenectomy in cervical cancer: a comparative study. (1993) (103)
Paraaortic Lymph Node Radiotherapy in Cancer of the Uterine Corpus (1985) (94)
Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue. (2000) (94)
Malignant mixed müllerian tumor versus high-grade endometrial carcinoma and aggressive variants of endometrial carcinoma: a comparative analysis of survival. (1995) (90)
Trophoblastic pseudotumor-evidence of malignant disease potential. (1981) (87)
Dietary associations in a case-control study of endometrial cancer (1993) (85)
Mitotic count, nuclear atypia, and immunohistochemical determination of Ki-67, c-myc, p21-ras, c-erbB2, and p53 expression in granulosa cell tumors of the ovary: mitotic count and Ki-67 are indicators of poor prognosis. (1996) (83)
The revised Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda workshop. (1992) (80)
Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience? (1993) (79)
Human genital papilloma infections: an evaluation of immunologic competence in the genital neoplasia-papilloma syndrome. (1986) (77)
Past and present physical activity and endometrial cancer risk. (1993) (76)
Flow Characteristics in Benign and Malignant Gynecologic Tumors Using Transvaginal Color Flow Doppler (1994) (74)
Prognostic significance of the presence of human papillomavirus DNA in patients with invasive carcinoma of the cervix (1989) (73)
Human papillomavirus DNA in adenocarcinoma in situ, microinvasive adenocarcinoma of the uterine cervix, and coexisting cervical squamous intraepithelial neoplasia. (1989) (72)
Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types. (2010) (71)
The role of surgical debulking in cancer of the uterine cervix. (1989) (67)
Presence of human papillomavirus in verrucous carcinoma (Ackerman) of the vagina. Immunocytochemical, ultrastructural, and DNA hybridization studies. (1984) (63)
Detection of human papillomavirus DNA in invasive carcinomas of the cervix by in situ hybridization. (1987) (62)
Histological types of carcinoma of the uterine cervix and the detectability of human papillomavirus DNA. (1985) (61)
Cytoplasmic estrogen and progesterone receptors as prognostic parameters in primary endometrial carcinoma (1986) (59)
Human ovarian epithelial cancer cells cultured in Vitro express both interleukin 1α and β genes (1992) (59)
Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study) (1989) (59)
Small‐cell carcinoma of the endometrium: Light microscopic and ultrastructural study of a case (1982) (57)
Single‐dose actinomycin‐D treatment for nonmetastatic gestational trophoblastic disease: A prospective phase II trial of the gynecologic oncology group (1987) (57)
Role of whole abdominal radiation therapy in the management of endometrial cancer; prognostic importance of factors indicating peritoneal metastases. (1985) (55)
A Prospective Randomized Comparison of Methotrexate, Dactinomycin, and Chlorambucil Versus Methotrexate, Dactinomycin, Cyclophosphamide, Doxorubicin, Melphalan, Hydroxyurea, and Vincristine in “Poor Prognosis” Metastatic Gestational Trophoblastic Disease: A Gynecologic Oncology Group Study (1989) (55)
Oral contraceptive use and risk of gestational trophoblastic tumors. (1999) (54)
Invasive vulvar tumors in young women--a disease of the immunosuppressed? (1993) (52)
Acute pulmonary complications of molar pregnancy. (1979) (50)
Spectroscopic Imaging as a Triage Test for Cervical Disease: A Prospective Multicenter Clinical Trial (2006) (50)
Phase I trial of taxol as a radiation sensitizer with cisplatin in advanced cervical cancer. (1997) (50)
Human Papillomavirus DNA in Glandular Dysplasia and Microglandular Hyperplasia: Presumed Precursors of Adenocarcinoma of the Uterine Cervix (1989) (49)
Oral contraceptives and endometrial cancer: Do other risk factors modify the association? (1993) (49)
Moderate alcohol consumption and the risk of endometrial cancer. (1993) (49)
The effect of sartorius transposition on wound morbidity following inguinal-femoral lymphadenectomy. (1997) (47)
Association of Ki-ras with amplified DNA sequences, detected in human ovarian carcinomas by a modified in-gel renaturation assay. (1989) (47)
Pelvic adhesion formation after pelvic lymphadenectomy: comparison between transperitoneal laparoscopy and extraperitoneal laparotomy in a porcine model. (1994) (46)
Early invasive and in situ warty carcinoma of the vulva: clinical, histologic, and electron microscopic study with particular reference to viral association. (1982) (46)
Rectus abdominis myocutaneous flap for primary vaginal reconstruction. (1993) (46)
The morbidity and utility of periaortic radiotherapy in cervical carcinoma. (1983) (45)
Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study. (2004) (44)
Identification of Human Papillomavirus DNA in Cervical and Vaginal Intraepithelial Neoplasia with Molecularly Cloned Virus‐Specific DNA Probes (1983) (43)
Blood flow characteristics of ovarian tumors: implications for ovarian cancer screening. (1995) (42)
Circadian-timed Combination Doxorubicin-cisplatin Chemotherapy for Advanced Endometrial Carcinoma: A Phase Ii Study of the Gynecologic Oncology Group (1993) (42)
Cytoplasmic estrogen and progesterone receptors in primary cervical carcinoma: clinical and histopathologic correlates. (1983) (41)
Therapeutic implications of the natural history of advanced cervical cancer as defined by pretreatment surgical staging (1985) (40)
Primary malignant melanoma of the vagina: a clinicopathological analysis of 10 cases. (1990) (40)
Human Papillomavirus DNA in Adenosquamous Carcinoma and Squamous Cell Carcinoma of the Vulva (1988) (38)
Sensitivity of koilocytosis, immunocytochemistry, and electron microscopy as compared to DNA hybridization in detecting human papillomavirus in cervical and vaginal condyloma and intraepithelial neoplasia. (1986) (37)
Cigarette smoking and the risk of endometrial cancer. (1993) (37)
Prognostic importance of progesterone and estrogen receptors in cancer of the uterine cervix (1986) (37)
Endometrial cancer risk in relation to serum lipids and lipoprotein levels. (1994) (36)
α‐1 acid glycoprotein is an immunosuppressive factor found in ascites from ovarian carcinoma (1997) (35)
Gynecologic reconstruction with a rectus abdominis myocutaneous flap: an update. (1996) (35)
Circadian‐Timed Combination Doxorubicin‐Cisplatin Chemotherapy for Advanced Endometrial Carcinoma: A Phase II Study of the Gynecologic Oncology Group (1990) (35)
Vulvar melanoma: a microstaging study. (1982) (33)
Logistic models for prediction of enteric morbidity in the treatment of ovarian and cervical cancers. (1983) (32)
Mixed intestinal adenocarcinoma-argentaffin carcinoma of the vagina. (1986) (29)
Intrauterine device use and endometrial cancer risk. (1997) (29)
Condylomatous Carcinoma of the Vulva With Special Reference to Human Papillomavirus DNA (1988) (29)
Single-dose actinomycin-D treatment for nonmetastatic gestational trophoblastic disease (1986) (28)
The implementation of critical pathways in gynecologic oncology in a managed care setting: a cost analysis. (2001) (27)
Effect of cis‐Platinum on Tolerance to Radiation Therapy in Advanced Cervical Cancer (1986) (26)
Carcinoma of the cervix, FIGO Stage IB: treatment failures. (1984) (26)
The impact of extraperitoneal surgical staging on morbidity and tumor recurrence following radiotherapy for cervical carcinoma (1984) (25)
Transvaginal sonography as an aid in the clinical staging of carcinoma of the cervix (1992) (25)
Metastatic placental site trophoblastic tumor (1998) (25)
Vaginal recurrence of adenocarcinoma of the endometrium. (1980) (25)
Carcinoma of the uterine cervix FIGO Stage I-B. (1982) (25)
Vulvar Basal Cell Carcinoma: An Infrequently Metastasizing Neoplasm (1987) (24)
A Clinical, Histopathologic, and Molecular Biologic Investigation of Vulvar Intraepithelial Neoplasia (1988) (24)
Histogenesis of cervical adenocarcinoma with reference to human papillomavirus-18 as a carcinogen. (1989) (24)
Transvaginal color flow Doppler sonography in the assessment of gestational trophoblastic disease (1993) (23)
Pulse actinomycin D scheduling in nonmetastatic gestational trophoblastic neoplasia: cost-effective chemotherapy. (1983) (23)
Pretreatment extraperitoneal surgical staging in primary carcinoma of the cervix uteri. (1984) (23)
Management of pelvic venous stenosis with intravascular stainless steel stents. (1995) (23)
A novel strategy using G-CSF to support EMA/CO for high-risk gestational trophoblastic disease. (1995) (22)
How accurate is the pelvic examination as compared to transvaginal sonography? A prospective, comparative study. (1994) (22)
Borderline and invasive epithelial ovarian tumors in young women (1993) (21)
The Analysis of Carcinomas of the Vagina for Human Papillomavirus DNA (1988) (21)
Alpha-1 acid glycoprotein is an immunosuppressive factor found in ascites from ovaria carcinoma. (1997) (20)
On the lack of demonstrated clinical benefit of neoadjuvant cisplatinum therapy for cervical cancer. (1993) (20)
Treatment of vaginal intraepithelial neoplasia with the CO2 laser. (1985) (19)
Chemoprophylaxis with oral ciprofloxacin in ovarian cancer patients receiving taxol. (1994) (19)
Ascites levels of haptoglobin in patients with ovarian cancer (1993) (19)
Multicenter Direct to Vial Evaluation of a Liquid-Based Pap Test (2004) (18)
Signet Ring Cell Lobular Carcinoma of the Breast Presenting in a Cervicovaginal Smear (2000) (18)
The Effect of Prolonged Cycles of Chemotherapy on Quality of Life in Gynaecologic Cancer Patients (1997) (18)
Concurrent weekly cis-platinum and radiotherapy in advanced cervical cancer: a preliminary dose escalating toxicity study. (1986) (18)
Human ovarian epithelial cancer cells cultures in vitro express both interleukin 1 alpha and beta genes. (1992) (18)
Analysis of histopathological features of endometrioid uterine carcinomas and epidemiologic risk factors. (1998) (17)
Tubal sterilization and risk of cancer of the endometrium. (2000) (17)
Prognostic significance of steroid receptors measured in primary metastatic and recurrent endometrial carcinoma. (1989) (16)
Gray scale and color flow Doppler characterization of uterine tumors. (1994) (16)
Tolerance and preliminary results of simultaneous therapy with radiation and cisplatin for advanced cervical cancer. (1988) (16)
Resolution of pulmonary metastases with chemotherapy in a patient with placental site trophoblastic tumor (1992) (16)
Multimodality therapy for advanced and recurrent vulvar squamous cell carcinoma. A pilot project. (1990) (15)
Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial carcinoma of the ovary. (2005) (15)
Cytosolic estrogen and progesterone receptors as prognostic parameters in stage IB cervical carcinoma. (1987) (15)
Gonadal tumors in patients with gonadal dysgenesis and sex chromosomal rings and fragments. (1984) (14)
Basal cell pseudopodia in cervical intraepithelial neoplasia; progressive reduction of number with severity: a morphometric quantification. (1981) (14)
Multimodal hyperspectroscopy as a triage test for cervical neoplasia: pivotal clinical trial results. (2013) (14)
Nonsurgical management strategies for the functional complications of ileocolonic continent urinary reservoirs. (1995) (14)
The utility and limitations of decision theory in the utilization of surgical staging and extended field radiotherapy in cervical cancer. (1984) (13)
Decision theory analysis of the enteric morbidity and surgical staging in the treatment of advanced cervical cancer. (1984) (13)
Erosion of an intraperitoneal chemotherapy catheter resulting in an enterovaginal fistula. (2000) (13)
Metastatic gestational trophoblastic neoplasia complicated by tumor lysis syndrome, heart failure, and thyrotoxicosis: a case report. (2010) (13)
Nonneoplastic Complications of Molar Pregnancy (1984) (13)
Resection of the Pubic Bone as an Adjunct to Management of Primary, Recurrent, and Metastatic Pelvic Malignancies (1989) (12)
Uterine malignancy predicted by transvaginal sonography and color flow Doppler ultrasonography (1993) (12)
Prediction of malignancy using transvaginal color flow Doppler in patients with gynecologic tumors (1992) (12)
2001 Consensus Guidelines for the Management of Women with Cervical Intraepithelial Neoplasia (2003) (12)
A Phase I Study using low-dose fractionated whole abdominal radiotherapy as a chemopotentiator to full-dose cisplatin for optimally debulked stage III/IV carcinoma of the endometrium. (2011) (11)
Pseudomyxoma Peritonei ‐ Experience from a Tertiary Referral Centre (1991) (11)
Symptomatic central venous thrombosis and long-term right atrial catheters. (1990) (11)
The interplay of local and distant control in the cure of cervical cancer (1990) (11)
Managing abnormal cytology results in pregnancy. (2005) (11)
Immunocytochemical evidence of heterogenous origin of α-fetoprotein in immature teratoma of the ovary (1985) (10)
Measurement of number and cross-sectional area of basal cell pseudopodia: a new morphometric method (1981) (10)
Clinical Applications of Molecular Biological Screening for Human Papillomavirus: Diagnostic Techniques (1992) (10)
Transforming Growth Factor-Alpha Levels in the Serum and Ascites of Patients withAdv anced Epithelial Ovarian Cancer (1999) (10)
ICRF‐159 (Razoxane) in Patients with Advanced Adenocarcinoma of the Endometrium A Gynecologic Oncology Group Study (1986) (9)
A prospective randomized comparison of methotrexate, Actinomycin-D, and chlorambucil (MAC) versus modified Bagshawe regimen in “poor-prognosis” gestational trophoblastic disease (1987) (8)
The utility of preoperative screening colonoscopy in gynecologic oncology. (1995) (8)
Colposcopy: Management options (2003) (8)
High-grade squamous intraepithelial lesions. (2003) (8)
Persistent Postmolar Gestational Trophoblastic Disease: Use of Transvaginal Sonography and Colour Flow Doppler (1993) (7)
The Costs of Carcinoma of the Cervix (1972) (7)
Automated Primary Screening Devices (2000) (6)
Serum levels of macrophage colony-stimulating factor in patients with ovarian cancer undergoing second-look laparotomy. (1992) (6)
Searching for an efficient institutional review board review model: Interrelationship of trainee-investigators, funding, and initial approval. (2005) (6)
High-Risk HPV DNA Testing and HPV-16/18 Genotyping: What Is the Clinical Application? (2011) (6)
Placental site trophoblastic tumor presenting with scalp metastases (1995) (5)
Preliminary report of toxicity in a randomized comparison of methotrexate, actinomycin D, and chlorambucil (MAC) versus modified Bagshawe regimen in “poor prognosis” gestational trophoblastic disease (1985) (5)
Major basic protein as a marker of malignant potential in trophoblastic neoplasia. (1996) (4)
Concomitant whole‐abdominal radiation and intraperitoneal chemotherapy in advanced ovarian carcinoma. A pilot study (1991) (4)
Recurrent squamous cell carcinoma in a rectus abdominis neovagina. (1995) (4)
93154903 Oral contraceptives and endometrial cancer: do other risk factors modify the association? (1994) (4)
Evidence Supporting the Current Management Guidelines for High-Grade Squamous Intraepithelial Lesion Cytology (2004) (4)
Surgical intervention following multimodality therapy for advanced cervical cancer. (1990) (4)
Infectious Morbidity After Radical Vulvectomy (1994) (4)
The Integration of Whole Abdominal Radiotherapy and Intraperitoneal Cisplatin into the Primary Management of Advanced Ovarian Carcinoma (1991) (3)
Human Papillomavirus Vaccination: The Policy Debate Over the Prevention of Cervical Cancer-A Commentary (2008) (3)
Laparoendoscopic single-site extraperitoneal aortic lymphadenectomy: first experience. (2011) (3)
A sea change in diagnosing and managing HPV and cervical disease-Part II (2002) (3)
Transvaginal ultrasound in gynecologic oncology. (1991) (3)
Hormone Replacement Therapy in Endometrial Cancer Survivors: New Perspectives After the Heart and Estrogen Progestin Replacement Study and the Women's Health Initiative (2006) (3)
Immunocytochemical evidence of heterogeneous origin of alpha-fetoprotein in immature teratoma of the ovary. (1985) (3)
Cross-protection from human papillomavirus 16/18 against types 45 and 31: fact or fancy? (2008) (3)
Quality of Life Assessment in Gynaecological Cancer Patients (1995) (3)
Association of Human Papillomavirus with Vulvar and Vaginal Intraepithelial Disease: Opportunities for Prevention (2008) (2)
How do you evaluate an atypical glandular cell papanicolaou smear with psammoma bodies present? (1997) (2)
Single agent weekly methotrexate (MTX) therapy in the treatment of nonmetastatic gestational trophoblastic disease (NMGTD) (1987) (2)
A Manual of Clinical Colposcopy (1999) (2)
A simplified method for detubularization in the construction of a continent ileocolic reservoir (Miami pouch). (1997) (2)
Gravlee jet irrigator. Efficacy in diagnosis of endometrial neoplasia. (1976) (2)
Lack of adverse effect on quality of life of up to six cycles of chemotherapy in gynecologic cancer patients (1997) (2)
Editorial Board Symposium. Practical Approach to Cervical Human Papillomavirus–Related Intraepithelial Lesions (1989) (2)
Basal cell pseudopodia and the degree of maturation of squamous metaplasia of the uterine cervix: a morphometric quantification. (1983) (2)
Surgical intervention following multimodality therapy for advanced cervical cancer (1991) (2)
Treatment of advanced ovarian carcinoma with high-dose cyclophosphamide after falure on melphalan. (1977) (2)
Documentation of subclinical trophoblastic embolization with invasive cardiac monitoring in a woman with a molar pregnancy. A case report. (1986) (2)
Marker rhythmometry with macrophage-colony stimulating factor (M-CSF). (1991) (2)
Metastatic placental site trophoblastic tumor. (1998) (1)
Analysis of Histopathological Features of Endometrioid Uterine (2012) (1)
A Manual of Clinical Laparoscopy (1999) (1)
Management of complications of laparoscopic surgery in gynaecology (1993) (1)
Placental protein 5 in gestational trophoblastic disease: localization and circulating levels. (1982) (1)
The impact of nodal involvement and recurrence status on operative morbidity of pretreatment surgical staging in cervical carcinoma (1990) (1)
Teniposide in epithelial ovarian carcinoma: a phase II trial of the Gynecologic Oncology Group. (1986) (1)
A Comparison of Vascular Pulsatility and Resistive Indices in Gynecological Tumor Detection Using Transvaginal Ultrasound (1995) (1)
Is colposcopy and/or biopsy always necessary? (2013) (1)
Acute pulmonary complications of molar pregnancy (1980) (1)
Unilateral twin interstitial ectopic pregnancy. Report of a case. (1977) (1)
Gravlee Jet Irrigator as a Screening Method?-Reply (1976) (1)
Translocation of microbial organisms to pelvic lymph nodes as a possible cause of postoperative infection in gynecologic oncology patients (1992) (1)
A Decision Theory Analysis of Radiotherapeutic and Chemotherapeutic Toxicity in the Management of Ovarian Cancer (1986) (1)
The place of colposcopy and related systems in gynecological practice and research. (1989) (1)
100 Interactive Basic and Advanced Case-Studies (2001) (0)
Detection of Human Papillomavirus DNA in Invasive Carcinomas of the Cervix by in Situ Hybridization 1 (2006) (0)
Serum levels of macrophage colony‐stimulating factor in patients with ovarian cancer undergoing second‐look laparotomy (1992) (0)
EPIDEMIOLOGY Volume 137 (1993) (0)
Enumeration of the number of microprocesses of cultured murine T-lymphoma cells: A comparative study of two new morphometric methods (1983) (0)
Home study course: spring 2004. (2004) (0)
The rationalization for infrequent Pap smears. (1982) (0)
Editorial: Identifying gaps in the knowledge base underlying cervical cytology guidelines (2002) (0)
Spectroscopie lmaging as a Triage Test for Cervical Disease : A Prospective Multicenter Clinical Trial (2014) (0)
Genital Neoplasia-Papilloma Syndrome: A Unifying Concept of Human Genital Papillomavirus Infection and Expression (1986) (0)
Safety and efficacy of pegfilgrastim administration on the same day as myelosuppressive chemotherapy (CT) in women with ovarian or primary peritoneal cancer (2007) (0)
Pastandpresent physical activity andendometrial cancerrisk (1993) (0)
Transvaginal color flow Doppler and the detection of pelvic malignancies (1992) (0)
Use of positron emission tomography (PET) scan versus surgical staging in the pre-treatment evaluation of locally advanced cervical carcinoma: A cost effectiveness analysis (2012) (0)
Pre- and postevacuation hemodynamic and metabolic studies of hydatidiform mole and severe pregnancy-induced hypertension. A case report. (1980) (0)
Concomitant whole abdominal radiation and intraperitoneal cisplatin chemotherapy in advanced ovarian carcinoma: A pilot study (1990) (0)
A cost effectiveness analysis of the use of Positron Emission Tomography (PET) scan in the pre-treatment evaluation of stage I cervical carcinoma (2012) (0)
00024 RADICAL ABDOMINAL HYSTERECTOMY FOR INVASIVE CERVICAL CANCER AT THE UNIVERSITY OF MIAMI: A LOOK AT OUR 40-YEAR EXPERIENCE (2005) (0)
Significance of pregnancy-associated major basic protein (pMBP) in trophoblastic disease (1992) (0)
How should a patient with a series of abnormal pap smears be managed? (2001) (0)
Levels of macrophage colony-stimulating factor (M-CSF), interleukin-1 (IL-1), interleukin-6 (IL-6) and TNF alpha in human ovarian cancer (1991) (0)
A 23-year-old woman has her first Pap smear, thin prep smear interpreted as "high grade squamous intraepithelial lesion". (2008) (0)
Clinical question: ask the experts. (2004) (0)
Cytosolic estrogen and progesterone receptors in primary cervical carcinoma (1987) (0)
An Analysis of Adjuvant Treatment Strategies for Carcinoma of the Cervix (1989) (0)
Morphometric Analysis of Basal Cell-Stroma Interface in Normal and Abnormal Cervical Epithelium (1982) (0)
Takashi Okagaki, M.D., Ph.D., M.P.H. (1933-2010) (2011) (0)
Urinary diversion in pelvic exenteration: The role of conduit choice in postoperative morbidity (1991) (0)
Cardiac metastasis of cloacagenic carcinoma of the vagina: a case and review of gynecologic malignancies with cardiac metastasis. (2000) (0)
Improvement in MIA (OVA1) testing for detection of ovarian malignancy (2020) (0)
A pilot study of alternating courses of cisplatin/cyclophosphamide and carboplatin/etoposide in advanced ovarian cancer (1994) (0)
Past and present physical activity and endometrial cancer risk.: 11 (1994) (0)
Outcome assessment of home parenteral nutrition in gynecologic malignancies: The University of Minnesota experience (1991) (0)
Human papillomavirus infection of the cervix in a 14-year-old girl. (2003) (0)
A 14-Year-Old Female With LSIL. (2002) (0)
The utility of preoperative screening colonoscopy in gynecologic oncology (1995) (0)
Clinical correlations in preinvasive and early invasive vulvar neoplasia: A subset of genital neoplasia papilloma syndrome (GENPS) (1984) (0)
Urinary tract infection in women with gynecologic malignancy (1992) (0)
Paracrine loop of immune suppression in ovarian cancer (1992) (0)
Development of two new monoclonal antibodies reactive to a unique antigenic determinant present on human ovarian cancer cells (1992) (0)
76 Twenty-five year outcome of sequential abdominopelvic radiotherapy and alkylating agent chemotherapy for ovarian carcinoma (1997) (0)
Clinical question: ask the expert. (2007) (0)

This paper list is powered by the following services:

Other Resources About Leo Twiggs

en.wikipedia.org

What Schools Are Affiliated With Leo Twiggs?

Leo Twiggs is affiliated with the following schools: